Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H H Blume

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 6, 2000
The biopharmaceutics classification system (BCS): class III drugs - better candidates for BA/BE waiver?H H Blume, B S Schug
Journal of Pharmaceutical Sciences|November 1, 1993
Bio-International 92, conference on bioavailability, bioequivalence, and pharmacokinetic studiesH H Blume, K K Midha
European Journal of Drug Metabolism and Pharmacokinetics|October 14, 2000
Biopharmaceutical characterisation of herbal medicinal products: are in vivo studies necessary?H H Blume, B S Schug
The Journal of Pharmacy and Pharmacology|May 15, 2002
Pharmaceutical quality of different Ginkgo biloba brandsS Kressmann, W E Müller, H H Blume
The Journal of Pharmacy and Pharmacology|December 24, 2002
Influence of pharmaceutical quality on the bioavailability of active components from Ginkgo biloba preparationsS Kressmann, A Biber, M Wonnemann, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|January 8, 2011
Observational study on the tolerability and safety of film-coated tablets containing ivy extract (Prospan® Cough Tablets) in the treatment of colds accompanied by coughingM Stauss-Grabo, S Atiye, A Warnke, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 31, 2009
Phenotyping with sulfasalazine - time dependence and relation to NAT2 pharmacogeneticsU D Kuhn, M Anschütz, K Schmücker, et al.
European Journal of Clinical Pharmacology|May 16, 2002
Dosage form-related food interaction observed in a marketed once-daily nifedipine formulation after a high-fat American breakfastB S Schug, E Brendel, M Wonnemann, et al.
British Journal of Clinical Pharmacology|June 6, 2002
The effect of food on the pharmacokinetics of nifedipine in two slow release formulations: pronounced lag-time after a high fat breakfastB S Schug, E Brendel, E Chantraine, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|January 11, 2005
Felodipine quantification in human plasma by high-performance liquid chromatography coupled to tandem mass spectrometryLuis H Migliorança, Rafael E Barrientos-Astigarraga, B S Schug, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 6, 2000
The biopharmaceutics classification system (BCS): class III drugs - better candidates for BA/BE waiver?H H Blume, B S Schug
Journal of Pharmaceutical Sciences|November 1, 1993
Bio-International 92, conference on bioavailability, bioequivalence, and pharmacokinetic studiesH H Blume, K K Midha
European Journal of Drug Metabolism and Pharmacokinetics|October 14, 2000
Biopharmaceutical characterisation of herbal medicinal products: are in vivo studies necessary?H H Blume, B S Schug
The Journal of Pharmacy and Pharmacology|May 15, 2002
Pharmaceutical quality of different Ginkgo biloba brandsS Kressmann, W E Müller, H H Blume
The Journal of Pharmacy and Pharmacology|December 24, 2002
Influence of pharmaceutical quality on the bioavailability of active components from Ginkgo biloba preparationsS Kressmann, A Biber, M Wonnemann, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|January 8, 2011
Observational study on the tolerability and safety of film-coated tablets containing ivy extract (Prospan® Cough Tablets) in the treatment of colds accompanied by coughingM Stauss-Grabo, S Atiye, A Warnke, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 31, 2009
Phenotyping with sulfasalazine - time dependence and relation to NAT2 pharmacogeneticsU D Kuhn, M Anschütz, K Schmücker, et al.
European Journal of Clinical Pharmacology|May 16, 2002
Dosage form-related food interaction observed in a marketed once-daily nifedipine formulation after a high-fat American breakfastB S Schug, E Brendel, M Wonnemann, et al.
British Journal of Clinical Pharmacology|June 6, 2002
The effect of food on the pharmacokinetics of nifedipine in two slow release formulations: pronounced lag-time after a high fat breakfastB S Schug, E Brendel, E Chantraine, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|January 11, 2005
Felodipine quantification in human plasma by high-performance liquid chromatography coupled to tandem mass spectrometryLuis H Migliorança, Rafael E Barrientos-Astigarraga, B S Schug, et al.
Pageof 2